Oct. 23 at 5:20 PM
$PHRRF This is from the initial PR October 1, 2025, announcing the
$25M deal:
“This transaction validates the significant value embedded in our ketamine assets,” said Fabio Chianelli, Chief Executive Officer of PharmaTher.
Interestingly, the PPS and MC are both down significantly since that announcement
GLTA shareholders